Therapeutic Anticoagulation with Heparin in Patients with Covid-19. Reply

N Engl J Med. 2021 Nov 18;385(21):2014. doi: 10.1056/NEJMc2115560.

Authors

Ryan Zarychanski¹, Patrick R Lawler², Ewan Goligher³

Affiliations

¹ University of Manitoba, Winnipeg, MB, Canada ryan.zarychanski@umanitoba.ca.
² Peter Munk Cardiac Centre, Toronto, ON, Canada.
³ University of Toronto, Toronto, ON, Canada.

PMID: 34788517
DOI: 10.1056/NEJMc2115560

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants / adverse effects
Blood Coagulation / drug effects
COVID-19*
Heparin* / adverse effects
Humans
SARS-CoV-2

Substances

Anticoagulants
Heparin